Latest ViroPharma Incorporated Stories
DUBLIN, October 24, 2014 /PRNewswire/ -- - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014).
Company will draw on leaders' expertise in rare diseases, R&D and commercialization as it moves to complete development of its lead program in inherited blindness PHILADELPHIA, June
DUBLIN, May 1, 2014 /PRNewswire/ -- Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to March 31, 2014. Financial
EXTON, Pennsylvania, February 25, 2014 /PRNewswire/ -- ViroPharma Incorporated today announced the results of its tender offer (the "Convertible Notes Tender Offer") pursuant
DUBLIN, February 13, 2014 /PRNewswire/ -- - Shire expects similar Non GAAP earnings per ADS growth in 2014 - Shire (LSE: SHP, NASDAQ: SHPG) announces
DUBLIN, January 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced
DUBLIN, January 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a
- Sleep; the state or condition of being asleep.